Menstrual cycle influences endothelial progenitor cell regulation: A link to gender differences in vascular protection?

International Journal of Cardiology

Volumn 136, Issue 2, 2009, Pages 200-210

  Lemieux, Caroline ^a,b   Cloutier, Isabelle ^a   Tanguay, Jean François ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiovascular diseases; Circulation; Endothelial progenitor cells; Estrogen; Hormones

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; ESTRADIOL; ESTROGEN; HORMONE; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; ENDOTHELIAL STEM CELL; ENDOTHELIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HORMONE BLOOD LEVEL; HUMAN; MALE; MENARCHE; MENSTRUAL CYCLE; NORMAL HUMAN; ONSET AGE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; STEM CELL;

ADULT; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ESTROGENS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MENSTRUAL CYCLE; PREMENOPAUSE; SEX CHARACTERISTICS; STEM CELLS;

EID: 67650733453     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.054     Document Type: Article

References (33)

1. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 8 (Nov 2004) 318-322
2. Khakoo A.Y., and Finkel T. Endothelial progenitor cells. Annu Rev Med 56 (2005) 79-101
3. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 7 (Feb 13 2003) 593-600
4. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 10 (Sep 8 2005) 999-1007
5. Lloyd-Jones D.M., Larson M.G., Beiser A., and Levy D. Lifetime risk of developing coronary heart disease. Lancet 353 9147 (Jan 9 1999) 89-92
6. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 24 (Jun 24 2003) 3059-3065
7. Iwakura A., Luedemann C., Shastry S., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 25 (Dec 23 2003) 3115-3121
8. Iwakura A., Shastry S., Luedemann C., et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113 12 (Mar 28 2006) 1605-1614
9. Hamada H., Kim M.K., Iwakura A., et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114 21 (Nov 21 2006) 2261-2270
10. Imanishi T., Hano T., and Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23 9 (Sep 2005) 1699-1706
11. Bulut D., Albrecht N., Imohl M., et al. Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 96 5 (May 2007) 258-263
12. Hamelin B.A., Methot J., Arsenault M., et al. Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med 114 7 (May 2003) 599-602
13. Iwami Y., Masuda H., and Asahara T. Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 8 4 (Oct-Dec 2004) 488-497
14. Shantsila E., Watson T., and Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49 7 (Feb 20 2007) 741-752
15. Lloyd G.W., Patel N.R., McGing E., Cooper A.F., Brennand-Roper D., and Jackson G. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease?. Heart 84 2 (Aug 2000) 189-192
16. Kawano H., Motoyama T., Ohgushi M., Kugiyama K., Ogawa H., and Yasue H. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 135 11 (Dec 4 2001) 977-981
17. Mukamal K.J., Muller J.E., Maclure M., Sherwood J.B., and Mittleman M.A. Variation in the risk of onset of acute myocardial infarction during the menstrual cycle. Am J Cardiol 90 1 (Jul 1 2002) 49-51
18. Solomon C.G., Hu F.B., Dunaif A., et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87 5 (May 2002) 2013-2017
19. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 23 (Jun 10 1999) 1801-1811
20. Magkos F., Patterson B.W., and Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab 291 6 (Dec 2006) E1243-E1249
21. Ruiz-Sanz J.I., Navarro R., Martinez R., Hernandez M.L., Matorras R., and Ruiz-Larrea M.B. No effect of menstrual cycle on LDL oxidizability and particle size. Maturitas 57 3 (Jul 20 2007) 253-260
22. Hirata K., Shimada K., Watanabe H., et al. Modulation of coronary flow velocity reserve by gender, menstrual cycle and hormone replacement therapy. J Am Coll Cardiol 38 7 (Dec 2001) 1879-1884
23. Ekerhovd E., Enskog A., Caidahl K., et al. Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome. Hum Reprod 16 7 (Jul 2001) 1334-1339
24. Masuda H., Kalka C., Takahashi T., et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101 6 (Sep 14 2007) 598-606
25. Makinoda S., Mikuni M., Sogame M., et al. Erythropoietin, granulocyte-colony stimulating factor, interleukin-1 beta and interleukin-6 during the normal menstrual cycle. Int J Gynaecol Obstet 55 3 (Dec 1996) 265-271
26. Girling J.E., and Rogers P.A. Recent advances in endometrial angiogenesis research. Angiogenesis 8 2 (2005) 89-99
27. Kunz G.A., Liang G., Cuculi F., et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 152 1 (Jul 2006) 190-195
28. Drexler H., and Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 31 1 (Jan 1999) 51-60
29. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 8 (Aug 2004) 1983-1992
30. Caplan B.A., and Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 17 3 (May-Jun 1973) 401-417
31. Dimmeler S., and Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J Mol Med 82 10 (Oct 2004) 671-677
32. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 6 (Jun 2003) 702-712
33. Friedrich E.B., Walenta K., Scharlau J., Nickenig G., and Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98 3 (Feb 17 2006) e20-e25